MétaCan
Menu
← Back to cohort
Record W4407284966 · doi:10.1093/jcag/gwae059.080

A80 TIME-RESTRICTED FEEDING IMPROVES INFLAMMATORY AND METABOLIC BIOMARKERS IN CROHN’S DISEASE WITH OVERWEIGHT: A RANDOMIZED, PLACEBO-CONTROLLED PILOT TRIAL

2025· article· en· W4407284966 on OpenAlexaffabout
Natasha Haskey, A G Lewis, Celeste M. Lavallee, Munazza Yousuf, Lorian Taylor, Shamim Z. Jilani, Stephanie Gold, Ping Lu, Subrata Ghosh, R Panaccione, M Raman

Bibliographic record

VenueJournal of the Canadian Association of Gastroenterology · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsUniversity of CalgaryUniversity of British Columbia
Fundersnot available
KeywordsMedicinePlaceboOverweightCrohn's diseaseRandomized controlled trialDiseaseInternal medicinePhysical therapyObesityAlternative medicinePathology

Abstract

fetched live from OpenAlex

Abstract Background Time-restricted feeding (TRF), a form of intermittent fasting (IF), has shown promise for weight loss and metabolic health. Up to 40% of patients with Crohn’s disease (CD) have a BMI >25, which together with increased visceral adipose tissue (VAT) are independent risk factors for increased hospitalizations, early surgical interventions, and reduced responsiveness to pharmacotherapy. Effects of IF regarding metabolic and inflammatory biomarkers in CD remain limited. Aims To assess whether a TRF, compared to standard management (SM), affects inflammatory and metabolic biomarkers in CD patients with a BMI >25. Methods We conducted a 12-week (12W) pilot randomized controlled trial, recruiting patients with CD and overweight from Calgary/Kelowna. Participants were randomly assigned in a 1:1 ratio to either TRF or SM. The TRF group fasted for 16 hours daily and ate within an 8-hour window (16:8) for 6 days per week, without altering their habitual diet. The SM group continued their habitual diet. Results 35 patients completed the protocol (TRF=20; SM=15). Baseline characteristics were similar between groups, with a median BMI 28.0 kg/m2 [IQR:26-33.1]; median age 49 years [IQR:37-60]; 63% female with a median fecal calprotectin (FCP) 115 mcg/g [IQR:42-543]. There were no significant differences between groups in terms of diet, clinical disease activity or inflammatory and metabolic biomarkers at baseline. At 12W, the TRF group experienced a significant reduction in BMI (-0.9 kg/m2, P=0.007) and VAT (-194 cm3, P=0.008) while the SM group saw an increase in BMI (+0.2 kg/m2) and VAT (+78 cm3). FCP levels were either maintained or reduced (P=0.046), serum amyloid A significantly decreased (P<0.0001), with a trend toward improvement in the Harvey Bradshaw Index (P=0.061) in the TRF group, whereas in the SM group FCP, serum amyloid A, and the Harvey Bradshaw Index increased over the 12W. Serum markers leptin (P=0.002), adipsin (P=0.023), and plasminogen activator inhibitor-1 (P=0.045), significantly decreased in the TRF group. These changes were not observed in the SM group; the SM group saw an increase in IL-6 levels over the 12 weeks (P=0.001). Conclusions TRF led to significant improvements in BMI, VAT, and key metabolic markers, as well as decreases in systemic and gut inflammation, not observed in the SM group. These results highlight the potential of TRF as a complementary strategy for improving metabolic health and reducing inflammation in CD patients, warranting further investigation in larger studies. (NCT05230160). Funding Agencies Crohn’s & Colitis Foundation

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.008
Threshold uncertainty score0.027

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.002
Bibliometrics0.0010.001
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0080.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.003
GPT teacher head0.195
Teacher spread0.193 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJournal of the Canadian Association of Gastroenterology→Same topicInflammatory Bowel Disease→French-language works237,207→